Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (TCTR20251007008) titled 'A Phase 1 Study of the Safety, Tolerability, and Pharmacodynamics of REDGEM-S-DNA in Healthy Adults' on Oct. 7.
Study Type: Interventional
Study Design:
N/A
Primary Sponsor: REDGEM MOLECULE. Co.,LTd.
Condition:
Healthy Adults
Clinical Trials, Phase I as Topic
Drug Tolerance
Dose-Response Relationship, Drug
Pharmacodynamics
DNA, Recombinant / administration &
dosage
Plasmids / administration &
dosage
Nanoparticles / administration &
dosage
Gene Therapy / methods
Healthy Volunteers
Adult
Humans
Male
Female
Safety Management
Treatment Outcome
Clinical Trials, Phase I as Topic
Drug Tolerance
Dose-Respon...